-
1
-
-
0348135024
-
Dendritic-cell control of pathogen-driven T-cell polarization
-
Kapsenberg, M. L. 2003. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 3: 984-993.
-
(2003)
Nat. Rev. Immunol
, vol.3
, pp. 984-993
-
-
Kapsenberg, M.L.1
-
3
-
-
33745569040
-
Vaccination of Japanese patients with advanced melanoma with peptide, tumor lysate or both peptide and tumor lysate-pulsed mature, monocyte-derived dendritic cells
-
Nakai, N., J. Asai, E. Ueda, H. Takenaka, N. Katoh, and S. Kishimoto. 2006. Vaccination of Japanese patients with advanced melanoma with peptide, tumor lysate or both peptide and tumor lysate-pulsed mature, monocyte-derived dendritic cells. J. Dermatol. 33: 462-472.
-
(2006)
J. Dermatol
, vol.33
, pp. 462-472
-
-
Nakai, N.1
Asai, J.2
Ueda, E.3
Takenaka, H.4
Katoh, N.5
Kishimoto, S.6
-
4
-
-
33645297917
-
Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate
-
Salcedo, M., N. Bercovici, R. Taylor, P. Vereecken, S. Massicard, D. Duriau, F. Vernel-Pauillac, A. Boyer, V. Baron-Bodo, E. Mallard, et al. 2006. Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate. Cancer Immunol. Immunother. 55: 819-829.
-
(2006)
Cancer Immunol. Immunother
, vol.55
, pp. 819-829
-
-
Salcedo, M.1
Bercovici, N.2
Taylor, R.3
Vereecken, P.4
Massicard, S.5
Duriau, D.6
Vernel-Pauillac, F.7
Boyer, A.8
Baron-Bodo, V.9
Mallard, E.10
-
5
-
-
33748302109
-
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
-
Waeckerle-Men, Y., E. Uetz-von Allmen, M. Fopp, R. von Moos, C. Bohme, H. P. Schmid, D. Ackermann, T. Cerny, B. Ludewig, M. Groettrup, and S. Gillessen. 2006. Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma. Cancer Immunol. Immunother. 55: 1524-1533.
-
(2006)
Cancer Immunol. Immunother
, vol.55
, pp. 1524-1533
-
-
Waeckerle-Men, Y.1
Uetz-von Allmen, E.2
Fopp, M.3
von Moos, R.4
Bohme, C.5
Schmid, H.P.6
Ackermann, D.7
Cerny, T.8
Ludewig, B.9
Groettrup, M.10
Gillessen, S.11
-
6
-
-
34047201855
-
Immunotherapy of patients with hormone-refractory prostate carcinoma pre-treated with interferon-γ and vaccinated with autologous PSA-peptide loaded dendritic cells: A pilot study
-
Hildenbrand, B., B. Sauer, O. Kalis, C. Stoll, M. A. Freudenberg, G. Niedermann, J. M. Giesler, E. Juttner, J. H. Peters, B. Haring, et al. 2007. Immunotherapy of patients with hormone-refractory prostate carcinoma pre-treated with interferon-γ and vaccinated with autologous PSA-peptide loaded dendritic cells: a pilot study. Prostate 67: 500-508.
-
(2007)
Prostate
, vol.67
, pp. 500-508
-
-
Hildenbrand, B.1
Sauer, B.2
Kalis, O.3
Stoll, C.4
Freudenberg, M.A.5
Niedermann, G.6
Giesler, J.M.7
Juttner, E.8
Peters, J.H.9
Haring, B.10
-
7
-
-
33646480371
-
Peptide-loaded dendritic-cell vaccination followed by treatment interruption for chronic HIV-1 infection: A phase 1 trial
-
Ide, F., T. Nakamura, M. Tomizawa, A. Kawana-Tachikawa, T. Odawara, N. Hosoya, and A. Iwamoto. 2006. Peptide-loaded dendritic-cell vaccination followed by treatment interruption for chronic HIV-1 infection: a phase 1 trial. J. Med. Virol. 78: 711-718.
-
(2006)
J. Med. Virol
, vol.78
, pp. 711-718
-
-
Ide, F.1
Nakamura, T.2
Tomizawa, M.3
Kawana-Tachikawa, A.4
Odawara, T.5
Hosoya, N.6
Iwamoto, A.7
-
8
-
-
24744467809
-
Efficacy of antigen 2/proline-rich antigen cDNA-transfected dendritic cells in immunization of mice against Coccidioides posadasii
-
Awasthi, S., V. Awasthi, D. M. Magee, and J. J. Coalson. 2005. Efficacy of antigen 2/proline-rich antigen cDNA-transfected dendritic cells in immunization of mice against Coccidioides posadasii. J. Immunol. 175: 3900-3906.
-
(2005)
J. Immunol
, vol.175
, pp. 3900-3906
-
-
Awasthi, S.1
Awasthi, V.2
Magee, D.M.3
Coalson, J.J.4
-
9
-
-
0242578106
-
A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation
-
Bozza, S., K. Perruccio, C. Montagnoli, R. Gaziano, S. Bellocchio, E. Burchielli, G. Nkwanyuo, L. Pitzurra, A. Velardi, and L. Romani. 2003. A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation. Blood 102: 3807-3814.
-
(2003)
Blood
, vol.102
, pp. 3807-3814
-
-
Bozza, S.1
Perruccio, K.2
Montagnoli, C.3
Gaziano, R.4
Bellocchio, S.5
Burchielli, E.6
Nkwanyuo, G.7
Pitzurra, L.8
Velardi, A.9
Romani, L.10
-
10
-
-
33644879983
-
Dendritic cells transduced with recombinant adenoviruses induce more efficient anti-tumor immunity than dendritic cells pulsed with peptide
-
Oh, S. T., C. H. Kim, M. Y. Park, E. H. Won, H. J. Sohn, H. I. Cho, W. K. Kang, Y. K. Hong, and T. G. Kim. 2006. Dendritic cells transduced with recombinant adenoviruses induce more efficient anti-tumor immunity than dendritic cells pulsed with peptide. Vaccine 24: 2860-2868.
-
(2006)
Vaccine
, vol.24
, pp. 2860-2868
-
-
Oh, S.T.1
Kim, C.H.2
Park, M.Y.3
Won, E.H.4
Sohn, H.J.5
Cho, H.I.6
Kang, W.K.7
Hong, Y.K.8
Kim, T.G.9
-
11
-
-
33645507435
-
Development of cell-based tuberculosis vaccines: Genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterparts
-
Malowany, J. I., S. McCormick, M. Santosuosso, X. Zhang, N. Aoki, P. Ngai, J. Wang, J. Leitch, J. Bramson, Y. Wan, and Z. Xing. 2006. Development of cell-based tuberculosis vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterparts. Mol. Ther. 13: 766-775.
-
(2006)
Mol. Ther
, vol.13
, pp. 766-775
-
-
Malowany, J.I.1
McCormick, S.2
Santosuosso, M.3
Zhang, X.4
Aoki, N.5
Ngai, P.6
Wang, J.7
Leitch, J.8
Bramson, J.9
Wan, Y.10
Xing, Z.11
-
12
-
-
21344458843
-
Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transduced by adenoviral vectors encoding HBsAg: Comparison to protein immunization
-
Qiu, S. J., L. Lu, C. Qiao, L. Wang, Z. Wang, X. Xiao, S. Qian, J. J. Fung, S. L. Ye, and C. A. Bonham. 2005. Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transduced by adenoviral vectors encoding HBsAg: comparison to protein immunization. J. Cancer Res. Clin. Oncol. 131: 429-438.
-
(2005)
J. Cancer Res. Clin. Oncol
, vol.131
, pp. 429-438
-
-
Qiu, S.J.1
Lu, L.2
Qiao, C.3
Wang, L.4
Wang, Z.5
Xiao, X.6
Qian, S.7
Fung, J.J.8
Ye, S.L.9
Bonham, C.A.10
-
13
-
-
0035085492
-
Immunoglobulin A (IgA) responses and IgE-associated inflammation along the respiratory tract after mucosal but not systemic immunization
-
Hodge, L. M., M. Marinaro, H. P. Jones, J. R. McGhee, H. Kiyono, and J. W. Simecka. 2001. Immunoglobulin A (IgA) responses and IgE-associated inflammation along the respiratory tract after mucosal but not systemic immunization. Infect. Immun. 69: 2328-2338.
-
(2001)
Infect. Immun
, vol.69
, pp. 2328-2338
-
-
Hodge, L.M.1
Marinaro, M.2
Jones, H.P.3
McGhee, J.R.4
Kiyono, H.5
Simecka, J.W.6
-
14
-
-
20444403043
-
Mechanisms of mucosal and parenteral tuberculosis vaccinations: Adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen
-
Santosuosso, M., X. Zhang, S. McCormick, J. Wang, M. Hitt, and Z. Xing. 2005. Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen. J. Immunol. 174: 7986-7994.
-
(2005)
J. Immunol
, vol.174
, pp. 7986-7994
-
-
Santosuosso, M.1
Zhang, X.2
McCormick, S.3
Wang, J.4
Hitt, M.5
Xing, Z.6
-
15
-
-
33746632535
-
Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis
-
Santosuosso, M., S. McCormick, X. Zhang, A. Zganiacz, and Z. Xing. 2006. Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis. Infect. Immun. 74: 4634-4643.
-
(2006)
Infect. Immun
, vol.74
, pp. 4634-4643
-
-
Santosuosso, M.1
McCormick, S.2
Zhang, X.3
Zganiacz, A.4
Xing, Z.5
-
16
-
-
0032494186
-
Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable chlamydiae
-
Su, H., R. Messer, W. Whitmire, E. Fischer, J. C. Portis, and H. D. Caldwell. 1998. Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable chlamydiae. J. Exp. Med. 188: 809-818.
-
(1998)
J. Exp. Med
, vol.188
, pp. 809-818
-
-
Su, H.1
Messer, R.2
Whitmire, W.3
Fischer, E.4
Portis, J.C.5
Caldwell, H.D.6
-
17
-
-
0033023126
-
Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guérin-infected dendritic cells
-
Demangel, C., A. G. Bean, E. Martin, C. G. Feng, A. T. Kamath, and W. J. Britton. 1999. Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guérin-infected dendritic cells. Eur. J. Immunol. 29: 1972-1979.
-
(1999)
Eur. J. Immunol
, vol.29
, pp. 1972-1979
-
-
Demangel, C.1
Bean, A.G.2
Martin, E.3
Feng, C.G.4
Kamath, A.T.5
Britton, W.J.6
-
18
-
-
0035018250
-
Vaccination with Bordetella pertussis-pulsed autologous or heterologous dendritic cells induces a mucosal antibody response in vivo and protects against infection
-
George-Chandy, A., N. Mielcarek, I. Nordstrom, J. Holmgren, and K. Eriksson. 2001. Vaccination with Bordetella pertussis-pulsed autologous or heterologous dendritic cells induces a mucosal antibody response in vivo and protects against infection. Infect. Immun. 69: 4120-4124.
-
(2001)
Infect. Immun
, vol.69
, pp. 4120-4124
-
-
George-Chandy, A.1
Mielcarek, N.2
Nordstrom, I.3
Holmgren, J.4
Eriksson, K.5
-
19
-
-
35348890824
-
Dendritic cell- based vaccine against Coccidioides infection
-
Awasthi, S. 2007. Dendritic cell- based vaccine against Coccidioides infection. Ann. NY Acad. Sci. 1111: 269-274.
-
(2007)
Ann. NY Acad. Sci
, vol.1111
, pp. 269-274
-
-
Awasthi, S.1
-
20
-
-
4644309271
-
Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells
-
Wang, J., M. Santosuosso, P. Ngai, A. Zganiacz, and Z. Xing. 2004. Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells. J. Immunol. 173: 4590-4597.
-
(2004)
J. Immunol
, vol.173
, pp. 4590-4597
-
-
Wang, J.1
Santosuosso, M.2
Ngai, P.3
Zganiacz, A.4
Xing, Z.5
-
21
-
-
8444222278
-
Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis
-
Wang, J., L. Thorson, R. W. Stokes, M. Santosuosso, K. Huygen, A. Zganiacz, M. Hitt, and Z. Xing. 2004. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis. J. Immunol. 173: 6357-6365.
-
(2004)
J. Immunol
, vol.173
, pp. 6357-6365
-
-
Wang, J.1
Thorson, L.2
Stokes, R.W.3
Santosuosso, M.4
Huygen, K.5
Zganiacz, A.6
Hitt, M.7
Xing, Z.8
-
22
-
-
33846909485
-
Mucosal luminal manipulation of T cell geography switches on protective efficacy by otherwise ineffective parenteral genetic immunization
-
Santosuosso, M., S. McCormick, E. Roediger, X. Zhang, A. Zganiacz, B. D. Lichty, and Z. Xing. 2007. Mucosal luminal manipulation of T cell geography switches on protective efficacy by otherwise ineffective parenteral genetic immunization. J. Immunol. 178: 2387-2395.
-
(2007)
J. Immunol
, vol.178
, pp. 2387-2395
-
-
Santosuosso, M.1
McCormick, S.2
Roediger, E.3
Zhang, X.4
Zganiacz, A.5
Lichty, B.D.6
Xing, Z.7
-
23
-
-
0031113954
-
Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL
-
Brossart, P., A. W. Goldrath, E. A. Butz, S. Martin, and M. J. Bevan. 1997. Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. J. Immunol. 158: 3270-3276.
-
(1997)
J. Immunol
, vol.158
, pp. 3270-3276
-
-
Brossart, P.1
Goldrath, A.W.2
Butz, E.A.3
Martin, S.4
Bevan, M.J.5
-
24
-
-
0037443473
-
Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo
-
Kleindienst, P., and T. Brocker. 2003. Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo. J. Immunol. 170: 2817-2823.
-
(2003)
J. Immunol
, vol.170
, pp. 2817-2823
-
-
Kleindienst, P.1
Brocker, T.2
-
25
-
-
33745812070
-
Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection
-
Khader, S. A., S. Partida-Sanchez, G. Bell, D. M. Jelley-Gibbs, S. Swain, J. E. Pearl, N. Ghilardi, F. J. Desauvage, F. E. Lund, and A. M. Cooper. 2006. Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J. Exp. Med. 203: 1805-1815.
-
(2006)
J. Exp. Med
, vol.203
, pp. 1805-1815
-
-
Khader, S.A.1
Partida-Sanchez, S.2
Bell, G.3
Jelley-Gibbs, D.M.4
Swain, S.5
Pearl, J.E.6
Ghilardi, N.7
Desauvage, F.J.8
Lund, F.E.9
Cooper, A.M.10
-
26
-
-
0030790652
-
Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis
-
Cooper, A. M., J. Magram, J. Ferrante, and I. M. Orme. 1997. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186: 39-45.
-
(1997)
J. Exp. Med
, vol.186
, pp. 39-45
-
-
Cooper, A.M.1
Magram, J.2
Ferrante, J.3
Orme, I.M.4
-
27
-
-
0033214404
-
Dendritic cell (DC)-based anti-infective strategies: DCs engineered to secrete IL-12 are a potent vaccine in a murine model of an intracellular infection
-
Ahuja, S. S., R. L. Reddick, N. Sato, E. Montalbo, V. Kostecki, W. Zhao, M. J. Dolan, P. C. Melby, and S. K. Ahuja. 1999. Dendritic cell (DC)-based anti-infective strategies: DCs engineered to secrete IL-12 are a potent vaccine in a murine model of an intracellular infection. J. Immunol. 163: 3890-3897.
-
(1999)
J. Immunol
, vol.163
, pp. 3890-3897
-
-
Ahuja, S.S.1
Reddick, R.L.2
Sato, N.3
Montalbo, E.4
Kostecki, V.5
Zhao, W.6
Dolan, M.J.7
Melby, P.C.8
Ahuja, S.K.9
-
28
-
-
33646425837
-
Induction of Tc1 response and enhanced cytotoxic T lymphocyte activity in mice by dendritic cells transduced with adenovirus expressing HBsAg
-
Huang, Y., Z. Chen, H. Jia, W. Wu, S. Zhong, and C. Zhou. 2006. Induction of Tc1 response and enhanced cytotoxic T lymphocyte activity in mice by dendritic cells transduced with adenovirus expressing HBsAg. Clin. Immunol. 119: 280-290.
-
(2006)
Clin. Immunol
, vol.119
, pp. 280-290
-
-
Huang, Y.1
Chen, Z.2
Jia, H.3
Wu, W.4
Zhong, S.5
Zhou, C.6
-
29
-
-
0033605093
-
The effect of pre-existing adenovirus-specific immunity on immune responses induced by recombinant adenovirus expressing glycoprotein D of bovine herpesvirus type 1
-
Papp, Z., L. A. Babiuk, and M. E. Baca-Estrada. 1999. The effect of pre-existing adenovirus-specific immunity on immune responses induced by recombinant adenovirus expressing glycoprotein D of bovine herpesvirus type 1. Vaccine 17: 933-943.
-
(1999)
Vaccine
, vol.17
, pp. 933-943
-
-
Papp, Z.1
Babiuk, L.A.2
Baca-Estrada, M.E.3
-
30
-
-
0028937785
-
Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses
-
Yang, Y., Q. Li, H. C. Ertl, and J. M. Wilson. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69: 2004-2015.
-
(1995)
J. Virol
, vol.69
, pp. 2004-2015
-
-
Yang, Y.1
Li, Q.2
Ertl, H.C.3
Wilson, J.M.4
-
31
-
-
33745247366
-
Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients
-
Wierecky, J., M. R. Muller, S. Wirths, E. Halder-Oehler, D. Dorfel, S. M. Schmidt, M. Hantschel, W. Brugger, S. Schroder, M. S. Horger, et al. 2006. Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients. Cancer Res. 66: 5910-5918.
-
(2006)
Cancer Res
, vol.66
, pp. 5910-5918
-
-
Wierecky, J.1
Muller, M.R.2
Wirths, S.3
Halder-Oehler, E.4
Dorfel, D.5
Schmidt, S.M.6
Hantschel, M.7
Brugger, W.8
Schroder, S.9
Horger, M.S.10
-
32
-
-
21244506203
-
+ T cells in patients with metastatic melanoma vaccinated with antigen-pulsed dendritic cells
-
+ T cells in patients with metastatic melanoma vaccinated with antigen-pulsed dendritic cells. J. Clin. Immunol. 25: 288-295.
-
(2005)
J. Clin. Immunol
, vol.25
, pp. 288-295
-
-
Palucka, A.K.1
Connolly, J.2
Ueno, H.3
Kohl, J.4
Paczesny, S.5
Dhodapkar, M.6
Fay, J.7
Banchereau, J.8
-
33
-
-
34748846272
-
Phase I/II study of vaccination with electrofused allogenic dendritic cells/autologous tumor-derived cells in patients with stage IV renal carcinoma
-
Avigan, D. E., B. Vasir, D. J. George, W. K. Oh, M. B. Atkins, D. F. McDermott, P. W. Kantoff, R. A. Figin, M. J. Vasconelles, Y. Xu, et al. 2007. Phase I/II study of vaccination with electrofused allogenic dendritic cells/autologous tumor-derived cells in patients with stage IV renal carcinoma. J. Immunother. 30: 749-761.
-
(2007)
J. Immunother
, vol.30
, pp. 749-761
-
-
Avigan, D.E.1
Vasir, B.2
George, D.J.3
Oh, W.K.4
Atkins, M.B.5
McDermott, D.F.6
Kantoff, P.W.7
Figin, R.A.8
Vasconelles, M.J.9
Xu, Y.10
-
34
-
-
34848827168
-
Induction of tumor-specific T-cell responses by vaccination with tumor lystae-loaded dendritic cells in colorectal cancer patients with carcinoembryonic-antigen positive tumors
-
Tamir, A., E. Basagila, A. Kagahzian, L. Jiao, S. Jensen, J. Nicholls, P. Tate, G. Stamp, F. Farzaneh, P. Harrison, et al. 2006. Induction of tumor-specific T-cell responses by vaccination with tumor lystae-loaded dendritic cells in colorectal cancer patients with carcinoembryonic-antigen positive tumors. Cancer Immunol. Immunother. 56: 2003-2016.
-
(2006)
Cancer Immunol. Immunother
, vol.56
, pp. 2003-2016
-
-
Tamir, A.1
Basagila, E.2
Kagahzian, A.3
Jiao, L.4
Jensen, S.5
Nicholls, J.6
Tate, P.7
Stamp, G.8
Farzaneh, F.9
Harrison, P.10
-
36
-
-
0035178909
-
Decreased interferon-α production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors
-
Feldman, S., D. Stein, S. Amrute, T. Denny, Z. Garcia, P. Kloser, Y. Sun, N. Megjugorac, and P. Fitzgerald-Bocarsly. 2001. Decreased interferon-α production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors. J. Clin. Immunol. 101: 201-210.
-
(2001)
J. Clin. Immunol
, vol.101
, pp. 201-210
-
-
Feldman, S.1
Stein, D.2
Amrute, S.3
Denny, T.4
Garcia, Z.5
Kloser, P.6
Sun, Y.7
Megjugorac, N.8
Fitzgerald-Bocarsly, P.9
-
37
-
-
0037217830
-
Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-infected individuals
-
Barron, M. A., N. Blyveis, B. E. Palmer, S. MaWhinney, and C. C. Wilson. 2003. Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-infected individuals. J. Infect. Dis. 187: 26-37.
-
(2003)
J. Infect. Dis
, vol.187
, pp. 26-37
-
-
Barron, M.A.1
Blyveis, N.2
Palmer, B.E.3
MaWhinney, S.4
Wilson, C.C.5
-
38
-
-
0035892117
-
+ (myeloid) dendritic cell numbers in primary HIV-1 infection
-
+ (myeloid) dendritic cell numbers in primary HIV-1 infection. Blood 98: 3016-3021.
-
(2001)
Blood
, vol.98
, pp. 3016-3021
-
-
Pacanowski, J.1
Kahi, S.2
Baillet, M.3
Lebon, P.4
Deveau, C.5
Goujard, C.6
Meyer, L.7
Oksenhendler, E.8
Sinet, M.9
Hosmalin, A.10
-
39
-
-
0038142359
-
Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1
-
Donaghy, H., B. Gazzard, F. Gotch, and S. Patterson. 2003. Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1. Blood 101: 4505-4511.
-
(2003)
Blood
, vol.101
, pp. 4505-4511
-
-
Donaghy, H.1
Gazzard, B.2
Gotch, F.3
Patterson, S.4
-
40
-
-
0033168137
-
Impaired ability of MHC class II-/- dendritic cells to provide tumor protection is rescued by CD40 ligation
-
Hermans, I. F., D. S. Ritchie, A. Daish, J. Yang, M. R. Kehry, and F. Ronchese. 1999. Impaired ability of MHC class II-/- dendritic cells to provide tumor protection is rescued by CD40 ligation. J. Immunol. 163: 77-81.
-
(1999)
J. Immunol
, vol.163
, pp. 77-81
-
-
Hermans, I.F.1
Ritchie, D.S.2
Daish, A.3
Yang, J.4
Kehry, M.R.5
Ronchese, F.6
-
41
-
-
31144469922
-
+ T cells are activated by "cross- dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines
-
+ T cells are activated by "cross- dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines. J. Immunol. 176: 1447-1455.
-
(2006)
J. Immunol
, vol.176
, pp. 1447-1455
-
-
Dolan, B.P.1
Gibbs Jr., K.D.2
Ostrand-Rosenberg, S.3
-
42
-
-
0031798137
-
Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells
-
Inaba, K., S. Turley, F. Yamaide, T. Iyoda, K. Mahnke, M. Inaba, M. Pack, M. Subklewe, B. Sauter, D. Sheff, et al. 1998. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med. 188: 2163-2173.
-
(1998)
J. Exp. Med
, vol.188
, pp. 2163-2173
-
-
Inaba, K.1
Turley, S.2
Yamaide, F.3
Iyoda, T.4
Mahnke, K.5
Inaba, M.6
Pack, M.7
Subklewe, M.8
Sauter, B.9
Sheff, D.10
-
43
-
-
38449100732
-
Antigen presentation by exosomes released from peptide-pulsed dendritic cells is not supressed by the presence of active CTL
-
Luketic, L., E. Frotten, J. Bramson, and Y. Wan. 2007. Antigen presentation by exosomes released from peptide-pulsed dendritic cells is not supressed by the presence of active CTL. J. Immunol. 179: 5024-5032.
-
(2007)
J. Immunol
, vol.179
, pp. 5024-5032
-
-
Luketic, L.1
Frotten, E.2
Bramson, J.3
Wan, Y.4
-
44
-
-
33749515495
-
Persistence and responsiveness of immunologic memory in the absence of secondary lymphoid organs
-
Moyron-Quiroz, J. E., J. Rangel-Moreno, L. Hartson, K. Kusser, M. P. Tighe, K. D. Klonowski, L. Lefrancois, L. S. Cauley, A. G. Harmsen, F. E. Lund, and T. D. Randall. 2006. Persistence and responsiveness of immunologic memory in the absence of secondary lymphoid organs. Immunity 25: 643-654.
-
(2006)
Immunity
, vol.25
, pp. 643-654
-
-
Moyron-Quiroz, J.E.1
Rangel-Moreno, J.2
Hartson, L.3
Kusser, K.4
Tighe, M.P.5
Klonowski, K.D.6
Lefrancois, L.7
Cauley, L.S.8
Harmsen, A.G.9
Lund, F.E.10
Randall, T.D.11
-
45
-
-
4644330206
-
Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity
-
Moyron-Quiroz, J. E., J. Rangel-Moreno, K. Kusser, L. Hartson, F. Sprague, S. Goodrich, D. L. Woodland, F. E. Lund, and T. D. Randall. 2004. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat. Med. 10: 927-934.
-
(2004)
Nat. Med
, vol.10
, pp. 927-934
-
-
Moyron-Quiroz, J.E.1
Rangel-Moreno, J.2
Kusser, K.3
Hartson, L.4
Sprague, F.5
Goodrich, S.6
Woodland, D.L.7
Lund, F.E.8
Randall, T.D.9
-
46
-
-
0032526925
-
Lack of both types 1 and 2 cytokines, tissue inflammatory responses, and immune protection during pulmonary infection by Mycobacterium bovis bacille Calmette-Guérin in IL-12-deficient mice
-
Wakeham, J., J. Wang, J. Magram, K. Croitoru, R. Harkness, P. Dunn, A. Zganiacz, and Z. Xing. 1998. Lack of both types 1 and 2 cytokines, tissue inflammatory responses, and immune protection during pulmonary infection by Mycobacterium bovis bacille Calmette-Guérin in IL-12-deficient mice. J. Immunol. 160: 6101-6111.
-
(1998)
J. Immunol
, vol.160
, pp. 6101-6111
-
-
Wakeham, J.1
Wang, J.2
Magram, J.3
Croitoru, K.4
Harkness, R.5
Dunn, P.6
Zganiacz, A.7
Xing, Z.8
|